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Abstract 
Review on t(20;21)(q11;q22), with data on clinics, 
and the genes involved. 
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Clinics and pathology 
Disease 
Acute myeloid leukaemia (AML) without 
maturation (M1- AML) in one case, AML with 
maturation (M2-AML) in one case; and blast crisis 
of myeloid type of chronic myelogenous leukaemia 
in two cases. 
Epidemiology 
Four cases available to date; three with 
t(20;21)(q11;q22) RUNX1/? (Misawa et al. 1986; 
Dube et al., 1989; Jeandidier et al., 2006), and one 
case with proved t(20;21)(q11.2;q22.1) 
RUNX1/NOL4L (Guastadisegni et al. 2010). They 




No additional anomaly in one case, monosomy 5 
and major karyotypic anomalies in one case,  
monosomy 7 in another case, and t(9;22)(q34;q11) 
in the remaining case. 
Genes involved and 
proteins 





Nothing is known concerning the domains of the 
protein, nor it's function. 
RUNX1 (runt-related transcription 




RUNX1, also called AML1 or CBFA2, contains a 
Runt domain and, in the C-term, a transactivation 
domain, an inhibition domain, and various 
regulatory regions; forms heterodimers; widely 
expressed; nuclear localization.  
RUNX1 is a transcription factor, critical regulator 
of hematopoietic-cell development.  
It binds to the core site 5' PyGPyGGTPy 3' of 
promotors and enhancers.  
RUNX1 is involved in many de novo and treatment 
related leukemias. 
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RUNX1 exon 6 was fused to NOL4L exon 8 in the 
case reported by Guastadisegni et al. 2010. 
Fusion protein 
Oncogenesis 
Wild-type NOL4L was expressed at low levels in 
AML and normal bone marrow, whereas the 
RUNX1/NOL4L was expressed at high levels 
(Guastadisegni et al. 2010). 
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